Explore Inventurus Knowledge Solutions IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Inventurus Knowledge Solutions Limited (IKS) is a technology-enabled healthcare solutions provider, offering a comprehensive care enablement platform to physician enterprises in the US, Canada, and Australia, with a primary focus on the US market. IKS supports outpatient and inpatient care organizations by enabling superior clinical outcomes, enhancing operational efficiencies, and optimizing revenue cycle management. The company's solutions alleviate administrative and operational burdens, allowing healthcare enterprises to focus on delivering better and more cost-effective patient care. With an asset-light global workforce and cutting-edge technology platforms, IKS partners with 778 healthcare organizations, including notable clients such as Mass General Brigham Inc. and Texas Health Care PLLC, as of September 30, 2024.
Key Points:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
Fields | Details |
---|---|
IPO Dates | 12 Dec - 16 Dec 2024 |
IPO Price Band | ₹1,265 - ₹1,329 per share |
Fresh Issue | NIL |
Offer For Sale | 18,795,510 shares |
Total IPO Size | ₹2,497.92 crore |
Face Value | ₹1 |
Listing On | BSE, NSE |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
Event | Date |
---|---|
IPO Opening Date | 12 Dec 2024 |
IPO Closing Date | 16 Dec 2024 |
Basis Of Allotment | 17 Dec 2024 |
Refunds | 18 Dec 2024 |
Demat Transfer | 18 Dec 2024 |
IPO Listing Date | 19 Dec 2024 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
Total Income | 784.47 | 1,060.16 | 1,857.94 | 1,294.61 |
Total Expenses | 496.21 | 669.91 | 1,416.27 | 1,028.57 |
Net Profit/Loss | 232.97 | 305.23 | 370.49 | 208.58 |
NPM (*) | 30.51 | 29.60 | 20.38 | 16.26 |
Total Assets | 787.52 | 988.31 | 3,027.52 | 2,790.52 |
Total Liabilities | 140.45 | 159.67 | 1,869.66 | 1,413.42 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
Period Ended | 31st March 2022 | 31st March 2023 | 31st March 2024 | Sep 2024 |
---|---|---|---|---|
EPS | 14.04 | 18.13 | 22.15 | 12.35 |
ROE (%) | 36.00 | 36.83 | 32.00 | 15.15 |
ROCE (%) | 49.82 | 49.43 | 31.56 | 13.79 |
D/E Ratio | NA | 2.06 | -0.06 | NA |
Current Ratio | 5.56 | 6.07 | 1.14 | 1.22 |
EBITDA MARGIN (%) | 36.33 | 34.95 | 28.62 | 27.99 |
* Compiled from DRHP/RHP for valuation purposes.
No listed peers available for comparison.
Investor Type | Shares Offered |
---|---|
Qualified Institutional Buyer (QIB) | Not less than 75% |
Non-Institutional Investor (NII/HNI) | Not less than 15% |
Retail Individual Investor (RII) | Not less than 10% |
Investor Type | Subscribed |
---|---|
Qualified Institutional Buyer (QIB) | 80.64 |
Non-Institutional Investor (NII/HNI) | 23.25 |
Retail Individual Investor (RII) | 14.55 |
Total | 52.68 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
Link Intime India Private Ltd
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Inventurus Knowledge Solutions Limited
Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, Maharashtra – 400 708, India
Phone: +91 22 3964 3205
Email: company.secretary@ikshealth.com
Website: https://www.ikshealth.com